[Featured Stock] Shinshin Pharmaceutical Rises on Selection as Major Contractor for US Federal Government
[Asia Economy Reporter Minji Lee] Shinshin Pharmaceutical is showing a sharp rise after news spread that it has entered the procurement market of the U.S. Department of Veterans Affairs.
At 10:55 AM on the 17th, Shinshin Pharmaceutical was trading at 7,080 KRW on the KOSDAQ market, up 26.43% from the previous session.
Hot Picks Today
Taking Annual Leave and Adding "Strike" to Profiles, "It Feels Like Samsung Has Collapsed"... Unsettled Internal Atmosphere
- There Is a Distinct Age When Physical Abilities Decline Rapidly... From What Age Do Strength and Endurance Drop?
- "One Comment Could Lead to a Report": 86% of Elementary Teachers Feel Anxious; Half Consider Resignation or Career Change
- "After Vowing to Become No. 1 Globally, Sudden Policy Brake Puts Companies’ Massive Investments at Risk"
- On Teacher's Day, a Student's Gifted Cake Had to Be Cut into 32 Pieces... Why?
The day before, Shinshin Pharmaceutical became the first domestic healthcare company to sign an e-commerce contract with the U.S. Department of Veterans Affairs. Accordingly, Shinshin Pharmaceutical registered eight topical anti-inflammatory and analgesic products, including Shinshin Pas Arex, with over 600 U.S. Department of Veterans Affairs hospital facilities and the U.S. General Services Administration's e-commerce shopping mall, GSA Advantage.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
